Specialised Services clinical commissioning policy: Emicizumab as prophylaxis in people with congenital haemophilia A with factor VIII inhibitors (all ages)

This activity is now closed…

Unfortunately, this activity is now closed and no more online responses will be accepted.

Return to overview page